The Effect of Cryocompression on Peripheral Neuropathy in Patients Receiving Chemotherapy for Gynecological Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMersin University
About this trial
Study Design:
This study is designed as a prospective, randomized controlled experimental study aiming to determine the effect of cryocompression therapy, applied during chemotherapy, on peripheral neuropathy symptoms in women with gynecologic cancers.
Research Hypotheses:
* H₀: Cryocompression therapy has no effect on peripheral neuropathy. * H₁: Cryocompression therapy has an effect on peripheral neuropathy.
Study Population:
The study population will consist of women over the age of 18 living in Mersin, Türkiye, who are diagnosed with gynecologic cancer and undergoing chemotherapy between August 10 and December 31, 2025.
Eligibility criteria
Qualifiers
Applying to Mersin University Hospital Oncology Outpatient Clinic
Willing to participate and providing signed informed consent
Able to read and write in Turkish
Accessible and able to communicate
Disqualifiers
Not applying to the specified outpatient clinic
No gynecologic cancer diagnosis or younger than 18 years old
Not providing informed consent
Not receiving weekly carboplatin + paclitaxel chemotherapy protocol
Trial design
Treatments tested in this trial
- cryocompression
Treatment groups
78 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov